Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T13:33:19.812Z Has data issue: false hasContentIssue false
This chapter is part of a book that is no longer available to purchase from Cambridge Core

12 - Botulinum toxin type A

(Onabotulinumtoxin A/Abobotulinumtoxin A)

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Nancy Muntner
Affiliation:
Neuroscience Education Institute
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 40 - 44
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ashkenazi, A, Silberstein, S. Is botulinum toxin useful in treating headache? Yes. Curr Treat Options Neurol 2009;11(1):18–23.Google Scholar
Klein, AW, Carruthers, A, Fagien, S, Lowe, NJ. Comparisons among botulinum toxins: an evidence-based review. Plast Reconstr Surg 2008;121(6):413e–422e.Google Scholar
Lennerstrand, G, Nordbø, OA, Tian, S, Eriksson-Derouet, B, Ali, T. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand 1998;76(1):27–7.Google Scholar
Mathew, NT, Jaffri, SF. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache 2009;49(10):1466–78.Google Scholar
Maurri, S, Brogelli, S, Alfieri, G, Barontini, F. Use of botulinum toxin in Meige's disease. Riv Neurol 1988;58(6):245–8.Google Scholar
Pappert, EJ, Germanson, T; ,Myobloc/Neurobloc European Cervical Dystonia Study Group. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial. Mov Disord 2008;23(4):510–7.Google Scholar
Petri, S, Tölle, T, Straube, A, Pfaffenrath, V, Stefenelli, U, Ceballos-Baumann, A; ,Dysport Migraine Study Group. Botulinum toxin as preventive treatment for migraine: a randomized double-blind study. Eur Neurol 2009;62(4):204–11.Google Scholar
Zesiewicz, TA, Stamey, W, Sullivan, KL, Hauser, RA. Botulinum toxin A for the treatment of cervical dystonia. Expert Opin Pharmacother 2004;5(9):2017–24.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×